期刊文献+

美国的儿科药品政策研究及对我国的启示 被引量:5

Pediatric Drug Policies in the USA and Its Illumination for China
原文传递
导出
摘要 目的:为我国建立促进儿科药品发展的相关政策提供借鉴和参考。方法:全面研究美国的儿科药品政策及其影响。结果与结论:美国在儿科药品方面实行的是强制加激励的政策,并已取得一定的效果。我国可以借鉴美国的成功经验,建立符合我国儿科药品现状的政策,促进儿科药品的发展,从而提高我国儿童健康水平。 OBJECTIVE: To provide reference for the enactment of policies related to pediatric drug development in China. METHODS: The pediatric drug policies of the USA and its impact were studied eomprehensively. RESULTS & CONCLUSIONS: The enforcement and stimulation policies were adopted in US for pediatric drug development, which achieved certain efficacy. China might as well draw the successful experiences from US to establish policies tailored to the status of pediatric drug development in order to promote pediatric drug development and improve the health level of Chinese children.
出处 《中国药房》 CAS CSCD 北大核心 2009年第28期2168-2170,共3页 China Pharmacy
关键词 美国 儿科药品 政策 USA Pediatric drug Policies
  • 相关文献

参考文献10

  • 1Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies[J ] .JAMA, 2003, 290(7) :905.
  • 2Mathis L. Growth and Development of Pediatric Drug Development at the FDA [EB/OL]. http://www.fda. gov/oc/opt/presentations/drugdevelopment .ppt. 2006- 06.2008- 07.
  • 3FDA. The Pediatric Exclusivity Provision [EB/OL]. http://www, fda .gov/cder/pediatric/reportcong01. pdf. 2001 - 01. 2008 - 07.
  • 4FDA. Food and Drug Administration Amendments Act of 2007[ EB/OL ] . http ://frwebgate. access, gpo. gov/cgi - bin/getdoc .cgi? dbname = 110_cong_public_ laws&docid = f:pub1085.110. 2007- 09. 2008- 07.
  • 5FDA.Best Pharmaceuticals for Children Act [EB/OL]. http ://www. fda. gov/opacom/laws/pharmkids/contents .html. 2002 - 01. 2008 - 07.
  • 6FDA. Guidance for Industry - Qualifying for Pediatric Exclusivity Under Section 505A of the Federal Food, Drug, and Cosmetic Act [ EB/OL ] . http ://www. fda .gov/cber/gdlns/pedexc .htm. 2008 - 07.
  • 7FDA. Pediatric Research Equity Act of 2003 [ EB/OL ]. http://www. fda. gov/cder/pediatric/S - 650 - PREA. pdf. 2003. 2008-07.
  • 8FDA. Pediatric Exclusivity Statistics as of October 31, 2008[ EB/OL ] . http ://www. fda. gov/cder/pediatric/ wrstats, htm. 2008- 10. 2008- 10.
  • 9FDA.Studies Breakdown Report for Issued Written Requests as of October 31, 2008[EB/ OL] . http:// www.fda.gov/cder/pediatric/breakdown.htm. 2008- 10. 2008- 10.
  • 10FDA. CDER 2007 Update Pediatric Drug Development [EB/OL]. http://www.fda.gov/Cder/reports/rtn/ 2007/6-pediatric-development. htm. 2007.2008 - 10.

同被引文献89

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部